Home » Transcept Strikes Home on Third Try for Insomnia Drug Intermezzo
Transcept Strikes Home on Third Try for Insomnia Drug Intermezzo
The FDA has approved Transcept Pharmaceuticals’ insomnia drug Intermezzo on its third NDA attempt that followed two complete response letters.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May